Response to ovarian stimulation is not impacted by a breast cancer diagnosis.

Response to ovarian stimulation is not impacted by a breast cancer diagnosis.

Item
http://www.wikidata.org/entity/Q38999007
Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?Recent advances in in vitro fertilization.Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle.Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature
P2860

Response to ovarian stimulation is not impacted by a breast cancer diagnosis.

Item
http://www.wikidata.org/entity/Q38999007
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
@en
type
label
Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
@en
prefLabel
Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698